HIV-Specific Poison May Complement ARVs
A study conducted in mice has shown that a toxin engineered to target HIV can eliminate infected immune cells in which the virus is replicating despite antiretroviral (ARV) therapy. This finding suggests that the toxin, called 3B3-PE38 and developed in 1998 in NIH (National Institutes of Health) labs, may one day serve as an adjunct to ARVs.